A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Clinical trial NCT07003425 · RECRUITING

Trial details

NCT number: NCT07003425
Sponsor: Apogee Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2025-05-14
Primary completion: 2029-12-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.